lucerastat | |
---|---|
Trade Name | |
Orphan Indication | Fabry disease |
USA Market Approval | USA |
USA Designation Date | 2015-10-29 00:00:00 |
Sponsor | Idorsia Pharmaceuticals US Inc.;1820 Chapel Avenue West, Suite 150;Cherry Hill, New Jersey, 08002 |
Related Access Program